Microcrystals for dissolution rate enhancement of poorly water-soluble drugs

Auweter, H., Bohn, H., Haberkorn, H., Horn, D., Luddecke, E., Rauschenberger, V., 1999. Production of carotenoid preparations in the form of coldwater-dispersible powders, and the use of the novel carotenoid preparations. US Patent No. 5968251. Buckton, 1997, Characterization of small changes in the physical properties of powders of significance for dry powder inhaler formulations, Adv. Drug Del. Rev., 26, 17, 10.1016/S0169-409X(97)00507-3 Chang, 1978, The surface tension of aqueous hydroxypropyl cellulose solutions, J. Colloid Interface Sci., 67, 255, 10.1016/0021-9797(78)90010-3 Chaumeil, 1998, Micronization: a method of improving the bioavailability of poorly soluble drugs, Meth. Find. Exp. Clin. Pharmacol, 20, 211, 10.1358/mf.1998.20.3.485666 Chiou, 1971, Pharmaceutical applications of solid dispersion systems, J. Pharm. Sci., 60, 1281, 10.1002/jps.2600600902 Cospite, 1989, Double-blind study of the pharmacodynamic and clinical activities of 5682 SE in venous insufficiency. Advantages of the new micronized form, Int. Angiol., 8, 61 Daniels, 1994, Pharmacopoeial cellulose ethers as oil-in-water emulsifiers. I. Interfacial properties, Eur. J. Pharm. Biopharm., 40, 128 Elamin, 1995, The use of amorphous model substances to study mechanically activated materials in the solid state, Int. J. Pharm., 199, 25, 10.1016/0378-5173(94)00364-B Feeley, 1998, Determination of surface properties and flow characteristics of salbutamol sulphate, before and after micronisation, Int. J. Pharm., 172, 89, 10.1016/S0378-5173(98)00179-3 Gaßmann, 1994, Hydrosols—alternatives for the parenteral application of poorly water-soluble drugs, Eur. J. Pharm. Biopharm., 40, 64 Horn, 1989, Preparation and characterisation of microdisperse bioavailable carotenoid hydrosols, Angew. Makrom. Chem., 166/167, 139, 10.1002/apmc.1989.051660110 Jacobs, 2000, Nanosuspensions as a new approach for the formulation for the poorly soluble drug tarazepide, Int. J. Pharm., 196, 161, 10.1016/S0378-5173(99)00412-3 Kerc, 1999, Micronization of drugs using supercritical carbon dioxide, Int. J. Pharm., 182, 33, 10.1016/S0378-5173(99)00063-0 Law, 1983, Adsorption of non-ionic water-soluble cellulose polymers at the solid–water interface and their effect on suspension stability, Int. J. Pharm., 15, 251, 10.1016/0378-5173(83)90159-X Löbenberg, 2000, Modern bioavailability, bioequivalence and biopharmaceutics classification system. New scientific approaches to international regulatory standards, Eur. J. Pharm. Biopharm., 50, 3, 10.1016/S0939-6411(00)00091-6 Müller, 1999, Nanosuspensionen—Formulierungen für schwerlösliche Arzneistoffe mit geringer Bioverfügbarkeit; 1. Herstellung und Eigenschaften, Pharm. Ind., 61, 74 Müller, 2001, Nanosuspensions as particulate drug formulations in therapy. Rationale for development and what we can expect for the future, Adv. Drug Del. Rev., 47, 2, 10.1016/S0169-409X(00)00118-6 Müller, 1996, Nanosuspensions for the i.v. administration of poorly soluble drugs—stability during sterilization and long-term storage, Proc. Intern. Symp. Control. Rel. Bioact. Mater., 22, 574 Parrott, E.L., 1990. Comminution. In: Swarbrick, J., Boylan, J.C. (Eds.), Encyclopedia of Pharmaceutical Technology, vol. 3. Marcel Decker, New York, pp. 101–121. Pedersen, 2000, A comparison of the solubility of danazol in human and simulated gastrointestinal fluids, Pharm. Res., 17, 891, 10.1023/A:1007576713216 Rasenack, 2002, Ibuprofen crystals with optimized properties, Int. J. Pharm., 245, 9, 10.1016/S0378-5173(02)00294-6 Schott, H., 1985. Colloidal dispersions. In: Remington’s Pharmaceutical Sciences. The Philadelphia College of Pharmacy and Science, Philadelphia, pp. 286–289. Serajuddin, 1999, Solid dispersion of poorly water-soluble drugs: early promises, subsequent problems, and recent breakthroughs, J. Pharm. Sci., 88, 1058, 10.1021/js980403l Shah, 1989, In vitro dissolution profile of water-insoluble drug dosage forms in the presence of surfactants, Pharm. Res., 6, 612, 10.1023/A:1015909716312 Steckel, 1997, Micronizing of steroids for pulmonary delivery by supercritical carbon dioxide, Int. J. Pharm., 152, 99, 10.1016/S0378-5173(97)00071-9 Szejtli, J., 1993. Cyclodextrin Technology. Kluwer Academic Publishers, Amsterdam. Ticehurst, 2000, Characterisation of the influence of micronisation on the crystallinity and physical stability of revatropate hydrobromide, Int. J. Pharm., 193, 247, 10.1016/S0378-5173(99)00347-6 Ward, 1995, Process-induced crystallinity changes in albuterol sulfate and its effect on powder physical stability, Pharm. Res., 12, 773, 10.1023/A:1016232230638 York, 1998, Characterisation of the surface energetics of milled dl-propranolol hydrochloride using inverse gas chromatography and molecular modelling, Int. J. Pharm., 174, 179, 10.1016/S0378-5173(98)00247-6